Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.

Goldminz AM, Botto NC, Gottlieb AB.

J Am Acad Dermatol. 2012 Nov;67(5):e237-8. doi: 10.1016/j.jaad.2012.04.045. No abstract available.

PMID:
23062936
2.

Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.

Ciurea AM, Guitart J, Brieva J.

Arch Dermatol. 2010 Jan;146(1):102-3. doi: 10.1001/archdermatol.2009.353. No abstract available.

PMID:
20083712
3.

Refractory pyoderma gangrenosum treated with infliximab in an infant.

Campos-Muñoz L, Conde-Taboada A, Aleo E, Toledano E, López-Bran E.

Clin Exp Dermatol. 2014 Apr;39(3):336-9. doi: 10.1111/ced.12297.

PMID:
24635074
4.

Infliximab as a treatment for recalcitrant pyoderma gangrenosum.

Singh M, Andrew SM, Lear JT.

Clin Exp Dermatol. 2004 Mar;29(2):196-7. No abstract available.

PMID:
14987282
5.

Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?

Adişen E, Oztaş M, Gürer MA.

Dermatology. 2008;216(2):163-5. doi: 10.1159/000111515. Epub 2008 Jan 23.

PMID:
18216480
6.

Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.

Handler MZ, Hamilton H, Aires D.

J Drugs Dermatol. 2011 Sep;10(9):1059-61.

PMID:
22052278
7.

Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.

Reddick CL, Singh MN, Chalmers RJ.

Dermatol Online J. 2010 Aug 15;16(8):15.

PMID:
20804692
8.

Ustekinumab for pyoderma gangrenosum.

Kluger N.

Arch Dermatol. 2012 May;148(5):655; author reply 656. doi: 10.1001/archdermatol.2012.78. No abstract available.

PMID:
22782165
9.

Ustekinumab for peristomal pyoderma gangrenosum.

Fahmy M, Ramamoorthy S, Hata T, Sandborn WJ.

Am J Gastroenterol. 2012 May;107(5):794-5. doi: 10.1038/ajg.2012.42. No abstract available.

PMID:
22552250
10.

Severe recalcitrant pyoderma gangrenosum treated with infliximab.

Kaur MR, Lewis HM.

Br J Dermatol. 2005 Sep;153(3):689-91. Review. No abstract available.

PMID:
16120178
11.

Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.

Del Giacco SR, Firinu D, Lorrai MM, Serusi L, Meleddu R, Barca MP, Peralta M, Manconi PE.

Acta Derm Venereol. 2012 Jul;92(4):439-40. doi: 10.2340/00015555-1301. No abstract available.

12.

Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.

Zaccagna A, Bertone A, Puiatti P, Picciotto F, Sprujevnik T, Santucci R, Rossini FP.

Eur J Dermatol. 2003 May-Jun;13(3):258-60.

PMID:
12804985
13.

Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.

Ueda M, Katoh M, Tanizaki H, Tanioka M, Matsumura Y, Miyachi Y.

Dermatol Online J. 2012 Jan 15;18(1):12.

14.

Six patients with pyoderma gangrenosum successfully treated with infliximab.

Mooij JE, van Rappard DC, Mekkes JR.

Int J Dermatol. 2013 Nov;52(11):1418-20. doi: 10.1111/j.1365-4632.2011.05201.x. Epub 2012 Apr 18. No abstract available.

PMID:
22512250
15.

Bronchopulmonary disease: an association with ulcerative colitis and pyoderma gangrenosum.

Kar PM, Aronoff G, Schuette P.

J Ky Med Assoc. 1993 Aug;91(8):320-3. No abstract available.

PMID:
8409712
16.

[Infliximab for a girl with refractory pyoderma gangrenosum].

Nozawa T, Hara R, Kinoshita J, Sano F, Miyamae T, Imagawa T, Mori M, Hirokado M, Takahashi K, Inayama Y, Yokota S.

Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):454-9. Japanese.

17.

Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests.

Uthman I, El-Sayad J, Sharara A.

Clin Exp Dermatol. 2005 May;30(3):294. No abstract available.

PMID:
15807693
18.

Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.

Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI.

Rom J Gastroenterol. 2005 Dec;14(4):401-3.

19.

Pyoderma gangrenosum.

Lerner J, Lerner M, Pasternack WA.

J Foot Ankle Surg. 1993 Nov-Dec;32(6):569-72. Review.

PMID:
8130785
20.

Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.

Guenova E, Teske A, Fehrenbacher B, Hoerber S, Adamczyk A, Schaller M, Hoetzenecker W, Biedermann T.

Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.

PMID:
21680759

Supplemental Content

Support Center